Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended April 2, 2006 for National Presto Industries, Inc. The filing includes significant restatements of previously reported financial data due to the reclassification of 7-day variable rate demand notes to marketable securities, adjustments to goodwill, and final allocation of the Amron purchase price. The company operates three segments: Housewares/Small Appliances, Defense Products, and Absorbent Products.
Key Financial Metrics
| Metric (in thousands) | Q1 2006 | Q1 2005 |
|---|---|---|
| Net Sales | $45,053 | $35,359 |
| Gross Profit | $5,284 | $5,140 |
| Operating Profit | $299 | $281 |
| Net Earnings | $1,918 | $1,276 |
| Diluted EPS | $0.28 | $0.19 |
| Cash from Operations | $2,251 | $1,056 |
| Cash & Equivalents (End) | $45,604 | $8,501 |
| Marketable Securities | $100,483 | $111,552 |
| Total Current Liabilities | $35,384 | $40,504 |
Liquidity: The current ratio was 6.2 to 1.0 as of April 2, 2006. Working capital decreased to $185,405,000.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 27% ($9.7M) driven primarily by the Defense Products segment, which grew 105% following the acquisition of Amron, LLC. Absorbent Products sales rose 32% due to adult incontinence line growth. Housewares sales declined 7% due to lower unit shipments.
- Profitability: Net earnings increased 50% ($642k). Operating profit remained relatively flat ($299k vs $281k) due to a significant loss in the Absorbent Products segment (-$1.8M operating loss) caused by startup inefficiencies and increased material costs, offset by strong performance in Defense Products.
- Other Income: Increased 74% to $2.0M, largely due to $500k in insurance proceeds for business interruption and higher interest income.
- Cash Flow: Operating cash flow improved to $2.3M. Investing activities used $4.3M, primarily for the Amron acquisition ($13.8M net cash outflow).
Outlook, Risks, and Unusual Items
- Acquisition Impact: The acquisition of Amron, LLC (Defense segment) was finalized in Q1 2006. The adjusted purchase price is $22.4M. Pro forma results suggest the acquisition significantly boosted sales and earnings.
- Plant Consolidation: The company initiated a consolidation of adult incontinence production from Marietta, GA to Eau Claire, WI. Estimated costs are $1.02M, including $190k in termination benefits. This is expected to improve long-term efficiency.
- Legal Proceedings: A significant SEC lawsuit alleging the company operated as an unregistered investment company was resolved in the company's favor by the 7th Circuit Court of Appeals in May 2007. However, the company's auditor (Grant Thornton LLP) withdrew its opinion, causing delays in filing subsequent 10-K and 10-Q reports. The NYSE granted an extension for the 2006 annual report filing.
- Accounting Restatements: The filing notes restatements regarding the classification of variable rate demand notes (now marketable securities) and adjustments to goodwill and product liability reserves.
Investor Verification Checklist
- Restatement Details: Verify the specific impact of the reclassification of variable rate demand notes on liquidity ratios and the final allocation of the Amron purchase price.
- Auditor Status: Confirm the status of the new audit engagement following the withdrawal of Grant Thornton LLP and the timeline for filing the delayed 2006 and 2007 reports.
- Absorbent Segment Turnaround: Monitor the Absorbent Products segment for signs of cost stabilization and efficiency gains following the plant consolidation and new machinery ramp-up.
- Dividend Sustainability: Review cash flow projections given the high dividend payout ($2.12 per share declared) relative to net earnings ($1.9M) and the cash used for acquisitions.
- Legal Finality: Confirm that the SEC litigation is fully closed with no further regulatory hurdles regarding the company's registration status.